已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Investigation of Current and Super‐Bore 088″ Treatment Strategies of Soft and Stiff Clots at Internal Carotid Artery and Middle Cerebral Artery Occlusion Sites in an In Vitro Thrombectomy Model

颈内动脉 医学 大脑中动脉 闭塞 血运重建 冲程(发动机) 溶栓 脑梗塞 外科 心脏病学 心肌梗塞 缺血 工程类 机械工程
作者
Raul G. Nogueira,John Thornton,Kevin Connolly,L Mullins,Seán Fitzgerald
出处
期刊:Stroke: vascular and interventional neurology [Wiley]
卷期号:2 (4): e000240-e000240 被引量:6
标识
DOI:10.1161/svin.121.000240
摘要

Background: Various mechanical thrombectomy devices including stent retrievers (STRs), contact aspiration (CA) catheters, and balloon guide catheters (BGCs) are used in both isolation and combination for the treatment of acute ischemic stroke. A new generation of Super-Bore 088″ aspiration catheters are being trialed clinically. We evaluated the in vitro revascularization performance of current and novel thrombectomy approaches in treating soft (red blood cell-rich) and stiff (fibrin/platelet-rich) clots at internal carotid artery (ICA) and middle cerebral artery (MCA) occlusion sites. Methods: National University of Ireland Galway Research Ethics Committee approved the study. Two human blood clot phenotypes were used to form ICA-terminus (20-mm) and MCA-M1 segment (10-mm) occlusions in an in vitro thrombectomy model. Thrombectomy setups tested were CA: Millipede 088, SOFIA Plus+conventional guide catheter, SOFIA Plus+BGC and C ombination; Millipede 088+STR, SOFIA Plus+BGC+STR, SOFIA Plus+conventional guide catheter+STR. Ten replicates of each experiment were performed totaling 120 tests. Revascularization endpoints were first-pass effect, final modified Thrombolysis in Cerebral Infarction (mTICI) 2c/3, and procedural-related distal emboli. Results: Millipede 088 CA achieved the highest first-pass effect rate in ICA-terminus (60%) and MCA-M1 segment (100%) occlusions and lowest number of procedural-related distal emboli compared with all other device setups, followed by the combined Millipede 088+STR technique. Amongst the conventional techniques, higher first-pass effect rates were observed with the combined technique using a BGC (40%) than 6F CA (20%) in ICA-terminus occlusions whereas the reverse was seen in MCA-M1 segment occlusions, with 6F CA performing better than combined approaches (60% versus 50%). BGCs may provide a revascularization benefit in ICA-terminus occlusions. Rates of first-pass effect and final mTICI 2c/3 were better for stiff clots compared with soft clots for all treatment approaches at both occlusion sites. Conclusion: Millipede 088 CA was the most effective technique for all clot types and occlusion locations. Across conventional techniques, CA seems to be more effective in MCA-M1 segment occlusions, while the combined technique performed better in ICA occlusions. Clot composition influences the success of each technique.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
慈溪的通稿完成签到,获得积分10
1秒前
安详慕卉发布了新的文献求助10
2秒前
予我而研完成签到 ,获得积分10
3秒前
仔哥完成签到 ,获得积分10
4秒前
Pami发布了新的文献求助10
4秒前
科研小白完成签到 ,获得积分20
5秒前
7秒前
徐甜完成签到 ,获得积分10
8秒前
甜蜜的飞绿的应助被Pami采纳,获得10
8秒前
予我而研关注了科研通微信公众号
9秒前
彭于晏的应助被GLW采纳,获得10
9秒前
yeahyeahhh完成签到,获得积分10
10秒前
绵绵发布了新的文献求助10
12秒前
12秒前
13秒前
Tzzl0226发布了新的文献求助30
16秒前
17秒前
英姑的应助被科研通管家采纳,获得10
17秒前
CipherSage的应助被科研通管家采纳,获得10
17秒前
LUX的应助被科研通管家采纳,获得50
17秒前
大模型的应助被科研通管家采纳,获得10
17秒前
我是老大的应助被科研通管家采纳,获得10
18秒前
随心完成签到 ,获得积分10
18秒前
19秒前
longer发布了新的文献求助10
20秒前
21秒前
科研通AI6.2的应助被Sqw采纳,获得10
22秒前
22秒前
22秒前
xxxmy发布了新的文献求助10
23秒前
初景发布了新的文献求助10
24秒前
24秒前
安兹乌尔恭完成签到 ,获得积分10
24秒前
梓辰完成签到 ,获得积分10
25秒前
25秒前
Aurinse发布了新的文献求助10
26秒前
26秒前
雪山大地发布了新的文献求助10
27秒前
精灵夜雨完成签到 ,获得积分10
27秒前
乖乖大王完成签到 ,获得积分10
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
自動車の空力技術 800
Using Projective Methods with Children 600
Organizational Behavior 510
Management and the Arts 510
Issues in Task-Based Language Teaching 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7784985
求助须知:如何正确求助?哪些是违规求助? 9324126
关于积分的说明 20397323
捐赠科研通 7373621
什么是DOI,文献DOI怎么找? 3321217
关于科研通互助平台的介绍 2469095
邀请新用户注册赠送积分活动 2337487